SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133801
Filing Date
2022-04-29
Accepted
2022-04-29 16:17:35
Documents
5
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d237826ddef14a.htm DEF 14A 429651
2 GRAPHIC g237826g00a00.jpg GRAPHIC 224510
3 GRAPHIC g237826g00a01.jpg GRAPHIC 114158
4 GRAPHIC g237826g00m61.jpg GRAPHIC 24894
5 GRAPHIC g237826g77q49.jpg GRAPHIC 44852
  Complete submission text file 0001193125-22-133801.txt   973926
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39344 | Film No.: 22875709
SIC: 2836 Biological Products, (No Diagnostic Substances)